Ahmed Magdy Rabea: Discussing new modalities in lung cancer management at Pfizer Egypt / Ahmed Magdy Rabea, cancer, Lung cancer, Lung Cancer Awareness,
archived 24 Nov 2024 13:07:34 UTC
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI / cancer, Dana-Farber’s Breast Oncology Center, Durvalumab, inflammatory breast
Discover ADCs for lung cancer, a new class of therapy created to attack tumor cells while reducing the toxicity on healthy cells.
Abstract. Acute promyelocytic leukemia (APL), a phenotypically and genotypically unique subtype of acute myeloid leukemia, has seen unprecedented advances
Multi-omic studies have identified three molecular separated pulmonary carcinoid (PC) subgroups (A1, A2, B) with distinctive mRNA expression profiles (e.g. OTP/ASCL1/HNF1A). We aimed to establish…
Key Points. SY-5609 repressed Myc, inhibited cell growth, induced lethality and depleted protein expressions in post-MPN sAML stem/progenitor cells.SY-5609
Combining predictive structural modeling and in vitro T-cell screens reveals the limitations of standard hybrid protein engineering and enables the design of highly functional MHC-independent…
Background The accuracy of prognostication has important implications for patients, families, and health services since it may be linked to clinical decision-making, patient experience and…
